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a b s t r a c t
The rare autosomal dominant condition Birt–Hogg–Dubé syndrome (BHD) is attributed to mutations on
chromosome 17 in the folliculin (FLCN) gene, but not always diagnosed due to lack of, or a variety of
symptoms such as ﬁbrofolliculomas, lung cystic lesions, spontaneous pneumothorax and renal cancer.
We hypothesized that the lack of or variability in symptoms could be due to BHD patients potentially
being abnormally susceptible to infections with human papillomavirus (HPV) or human polyomavirus
(HPyV), which can be associated with skin lesions or latency in the kidneys. Seven ﬁbrofolliculoma skin
lesions, one renal cancer and one lung cyst from nine patients with BHD treated at the Karolinska
University Hospital were therefore analyzed for cutaneous and mucosal HPV types and 10 HPyVs by bead
based multiplex assays or by PCR. All samples were negative for viral DNA. In conclusion, the data
suggest that HPV and HPyVs do not contribute to BHD pathology
& 2014 Elsevier Inc. All rights reserved.
Introduction
Birt–Hogg–Dubé syndrome (BHD) is autosomally dominant and
attributed to mutations on chromosome 17p12-q11.2 in the
folliculin (FLCN) gene encoding folliculin, a protein involved in
the mTOR pathway, but with an essentially unknown function.
(Birt et al., 1997; Khoo et al., 2001; Schmidt et al., 2001; Menko et
al., 2009). BHD patients may present with benign skin ﬁbrofolli-
culomas, trichodiscomas and acrochordons often after the age of
20 years, multiple lung cystic lesions, spontaneous pneumothorax
and renal cancer (Birt et al., 1997; Schmidt et al., 2001). However,
BHD is not always diagnosed, due to a wide clinical variability as
well as limited experience among health workers. (Menko et al.,
2009). Some patients and families present with only sporadic
cystic lung disease, pneumothorax or renal cancer or very few
unnoticed ﬁbrofolliculomas, Others may only have inconspicuous
ﬁbrofolliculomas, and it has been estimated that up to 25% of
FLCN-mutation carriers older than 20 years of age do not display
apparent skin lesions (Schmidt et al., 2005; Toro et al., 2008).
Facial angioﬁbromas and multiple small intraoral papules in the
mucosal surfaces of the lips, buccal mucosa and gingivae have also
occasionally been described in BHD as have other tumor types and
second hit mutations have been suggested in renal, but not skin
cancers (van Steensel et al., 2007; Menko et al., 2009). The
diagnosis of BHD is best performed by the detection of a patho-
genic FCLN germ line mutation (Khoo et al., 2001; Schmidt et al.,
2001).
BHD may thus solely be a genetic disease, but its variability in
the clinical presentation could also reﬂect upon a special sensitiv-
ity to an infectious agent, similar to that of e.g. Epidermodysplasia
verruciformis (EV) patients (Orth, 2006; Patel et al., 2010). Patients
with EV, have an inactivating mutation on either the EVER1/TMC6
or EVER2/TMC8 genes, also on chromosome 17, and exhibit special
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sensitivity to infections with certain common cutaneous human
papillomavirus (HPV) types (Orth, 2006; Patel et al., 2010). In
contrast to the general population, EV patients may upon e.g. HPV
type 5 infection develop pityriasis like macules, ﬂat wart-like and
cutaneous carcinomas (Orth, 2006).
Likely culprits in BHD could be different HPV types or human
polyomaviruses (HPyVs) with several new HPyVs detected since
2007, with some (e.g. MCV, HPyV6,7 and TSV) preferentially found in
skin, while others (e.g. BKV and JCV) are potentially latent in the
kidney (Feng et al., 2008; Schowalter et al., 2010; van der Meijden et
al., 2010; Dalianis and Hirsch, 2013; Ehlers and Wieland, 2013).
Furthermore, murine polyomavirus (MPyV), another member of the
polyomavirus (PyV) family often infects the skin, the kidneys and the
lung and can potentially induce many types of tumors (Berke and
Dalianis, 1993; Berke and Dalianis, 2000; Ramqvist and Dalianis,
2009). For this purpose we examined ﬁbrofolliculoma skin lesions of
seven patients with BHD, in addition to one lung cyst and one kidney
biopsy from two other BHD patients for the presence of 10 HPyVs
and for at least 44 HPVs including many occurring in the skin.
Results
In total nine biopsies from patients with BHD, (seven histo-
pathology veriﬁed skin ﬁbrofolliculomas, a renal cancer and a lung
biopsy including a cyst lesion) were included in this study. Patients
demographics and clinical features related to BHD are summarized
in Table 1. DNA was extracted from all the samples tested for the
presence of the 10 most recent human polyomaviruses (HPyVs)
and SV40 and LPyV. In addition, all samples were also tested for 44
HPV types, with the seven cutaneous samples tested for additional
cutaneous HPV-types. All samples were negative for all analyzed
viral DNA, with the exception of one ﬁbrofolliculoma skin sample,
which was very weakly positive for WUPyV and MCPyV, with
signals o0.1 viral genome per cell (Table 1).
Discussion
Here, seven skin lesion biopsies, one renal cancer biopsy and
one lung biopsy including typical lesions from nine patients with
BHD, were tested for the presence of HPV and HPyV DNA. All nine
samples were negative for the 44 HPVs and the 10 HPyVs included
in the analysis, with the exception of one skin sample, which was
very weakly positive (o0.1 copy/cell) for WUPyV and MCV. The
data thus suggest that none of the tested HPVs or HPyVs
contributed to BHD pathology.
Since BHD is an autosomal dominant condition with mutations in
the FLCN gene responsible for various symptoms associated with the
disease, this may not have been unexpected (Khoo et al., 2001;
Schmidt et al., 2001; Menko et al., 2009). However, our results do not
exclude the possibility that other infectious agents or additional
mutations may still be involved in the development of BHD. There is
a possibility that variants of one or several of the PyV included in the
assay have been present in the BHD samples but not detected due to
mismatch in the primer sequences. However, since the assay
includes two target regions (in ST and VP1) for each virus as well
as being run with an annealing temperature allowing for at least one
mismatch per primers, this is less likely.
With modern technologies, many new, hitherto unknown, infec-
tious agents have been detected, demonstrating how much we still
lack in our knowledge of such agents and in the diseases that they
may be associated with (Allander et al., 2005a,b, 2007; Dalianis and
Garcea, 2009; Dalianis and Hirsch, 2013; Ehlers and Wieland, 2013;
Foulongne et al., 2012; Hellwig and Gold, 2011; Johne et al., 2009:
Marra et al. 2003). Obvious examples include the detection of e.g. the
10 new HPyVs, where two MCV and TSV have been associated with
previously known rare diseases, i.e. Merkel Cell Carcinoma in the
elderly and Trichodyspasia spinulosa in immunosuppressed trans-
planted individuals (Feng et al., 2008; van der Meijden et al., 2010).
Another example is the development of progressive multifocal
leukoencephalopathy in multiple sclerosis patients after the intro-
duction of treatment with natalizumab (Hellwig and Gold, 2011).
Nevertheless, there are numerous studies that fail to identify
associations between infectious agents and diseases, or skin condi-
tions potentially caused by infectious. HPyVs and HPVs have e.g. not
been conﬁrmed in e.g. none sun-exposed melanomas or keratoa-
canthoma, nor in this study (Dahlgren et al., 2005; Giraud et al.,
2008b; Wieland et al., 2012; Ramqvist et al., 2014), However, MCV
sequences have been reported in nonmelanoma skin cancer of
immunosuppressed patients (Kassem et al., 2009).
In conclusion, our results indicate that the presently tested 10
HPyVs and the tested cutaneous and mucosal HPV types do not play a
major role in the pathology of BHD. However, this does still not
exclude the presence of variants of the above viruses, other viruses, or
other infectious agents. The search for associations between diseases
and infectious agents should still continue and could among this
group of patients be complemented by e.g. genome wide sequencing.
Material and methods
Patients
Between 2012 and 2014, 7 ﬁbrofolliculoma skin biopsies, 1 renal
cancer biopsy and 1 lung biopsy were collected from 9 patients
aged 28–75 years of age with BHD at the Karolinska University
Table 1
Some characteristics of the BHD patients and their lesions.
Patient code Gendera Ageb Family relations Pneumo-thorax Biopsy HPV and HPyV status
BHD-1 M 48 43 Renal cancer 0
BHD-2 M 65 Father of BHD-5 and BHDS-6 twin sisters 3 Folliculoma 0
BHD-3 M 75 30 Folliculoma WUPyV(3)c
MCV(9)c
BHD-4 M 45 410 Folliculoma 0
BHD-5 F 28 Daughter of BHD-2. Twin sister of BHD-6 1 Folliculoma 0
BHD-6 F 28 Daughter of BHD-2. Twin BHDS-5 0 Folliculoma 0
BHD-7 F 48 0 Folliculoma 0
BHD-8 M 68 Father of BHD-9 0d Folliculoma 0
BHD-9 F 45 Daughter of BHD-8 1 Lung cystic lesion 0
a M¼male, F¼ female.
b Years.
c Chronic obstructive lung disease.
d MFI values corresponding to signals o0.1 copy/cell.
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Hospital. Most patients presented with only skin manifestations,
but one patient presented with multiple renal cancers and
recurring pneumothorax episodes, while another patient aged 45
years, had a cystic lesion in the lung. Some of the patients'
characteristics obtained from the patients records are shown in
Table 1. The study was performed according to ethical permission
2012/83-31/2 obtained from the Stockholm Regional Ethical Com-
mittee at Karolinska Institutet.
DNA extraction
DNA extraction was performed from fresh frozen skin biopsies,
obtained after rinsing of the skin with saline and local anesthesia,
using the QIAmp DNA micro kit (Qiagen, Hilden, Germany)
protocol with minor modiﬁcations. Biopsy pieces were mixed
with 180 ml Buffer ATL, 20 ml Proteinase K and incubated overnight
at 56 1C. 200 ml Buffer AL and 200 ml 99% ethanol was then added
to the lysate followed by incubation at room temperature (RT) for
5 min. Lysate was transferred to QIAmp minElute Columns and
centrifuge for 1 min 8000 rpm. 500 ml Buffer AW1 was added to
the spin columns and centrifuged. This was repeated with 500 ml
Buffer AW2, and then centrifuged 8000 rpm for 3 min. The spin
columns were transferred to clean 2 ml eppendorf tubes and DNA
was eluted with 50 ml Buffer AE. DNA was stored at 20 1C. The
renal cancer biopsy was also fresh frozen and DNA extracted as
described above. The lung biopsy was formalin ﬁxed and parafﬁn
embedded. Two 5 mm thick sections and one blank counterpart
were cut and placed in two 1.5 ml Eppendorf tubes. DNA was
prepared using Roche High-Pure RNA parafﬁn kit (Roche Diag-
nostics) according to the manufacturer's instructions, but with
exclusion of the DNase treatment.
PCR-ampliﬁcation of PyV and β-globin DNA
For detection of 12 different PyVs a newly-developed PCR assay,
was used (Gustafsson et al., 2013). This assay simultaneously
targets the small T-antigen (ST) and viral protein 1 (VP1) region
of 10 human PyV; BKPyV, JCPyV, KIPyV, WUPyV, MCV, TSV,
MWPyV (HPyV10) HPyV6, 7, 9 and two primate PyVs; SV40 and
LPyV, together with β-globin. The primers and assay have pre-
viously been described in detail, (Gustafsson et al., 2013). The
β-globin primers were prolonged as described in Ramqvist et al.
(2014). Details of all included primers and probes can be requested
from the corresponding author. As described in Gustafsson et al.
(2013) the assay has a sensitivity of o5 genomes for each target,
with exception of a couple of targets, where the sensitivity was
o50 genomes. In addition, the sensitivity of the assay was also
validated with control viral DNA mixed with 50 ng human cellular
DNA before the PCR. Brieﬂy, the PCR was performed in a 25 ml
reaction mix containing 0.2 μM of each primer and Multiplex PCR
Master Mix (Qiagen). A denaturation step of 15 min at 94 1C was
followed by 40 cycles of 20 s at 94 1C, 90 s at 50 1C and 80 s at
71 1C. The PCR was terminated with a 4 min incubation at 71 1C.
The PCR was performed on 10 or 50 ng sample DNA with a
corresponding sample volume for blank samples, prepared
together with the BHD samples. As a positive general evaluation
of the PCR reaction, cellular DNA from the Siha cell line was
included in each assay in an amount corresponding to 5, 50 and
500 cell genomes. As positive HPyV controls, BKV and JCV positive
urine samples were included in the analysis.
Detection of PyV amplicons by a multiplex bead based assay
For the analysis of PyV amplicons, a bead-based multiplex assay
on a Magpix instrument (Luminex, Houston, TX, US) was used as
described previously (Gustafsson et al., 2013). 5 ml of the PCR
reaction was incubated for 30 min at 46 1C in a shaker set at
500 rpm, in a buffer consisting of 0.15 M tetramethylammonium
chloride, 12 mM Tris, 10 mM EDTA and 2.5 g/l sarkosyl with a pH of
8.0, together with a bead-mix consisting of 1000 beads of each of
the 25 different bead types, coupled with probes for ST or VP1, for
each of the 12 different PyVs and for β-globin. After washing the
beads were incubated for 30 min at room temperature with
streptavidin R-phycoerythrin conjugate (Life Technologies, CA,
USA) diluted 1:300 in 2.0 M tetramethylammonium chloride,
75 mM Tris, 6 mM EDTA and 1.5 g/l sarkosyl, with a pH of 8.0.
The output from the analysis on the MagPix instrument was given
as median ﬂuorescent index (MFI). A MFI value over 2 back-
groundþ20 was considered as a positive value. All samples with a
MFI value for β-globin 430 and were considered to have DNA of
enough quality for the analysis. All samples were evaluated in at
least two assays.
Analysis of DNA from mucosal and cutaneous HPV-types
Analysis for the presence of 27 different mucosal HPV types
(HPV6, 11, 16, 18, 26, 30, 31, 33, 35, 39, 42, 43, 44, 45, 51, 52, 53, 56,
58, 59, 66, 67, 68, 69, 70, 73 and 82) was also performed by PCR
followed by evaluation by a multiplex bead based assay on a
MagPix instrument as described previously (Nordfors et al., 2014).
For the PCR reaction 10 or 50 ng sample DNA was added in a 25 ml
reaction mix of which 5 ml was evaluated in the MagPix analysis.
As a positive control both for viral and cellular DNA, cellular DNA
corresponding to 5, 50 and 500 cell genomes from the HPV16
positive Siha cell line was included in each assay. To examine for
possible presence of cutaneous HPV DNA a PCR based on the CPI/
IIG primer set (Tieben et al., 1993) was run as described previously,
with SiHa also here included as a positive control (Mellin et al.,
2002). In addition to identify several mucosal HPV types, these
primers also detect cutaneous HPV types 1–5, 7–8, 10, 12, 14, 19–
22, 24–25, and 36. Thus in combination, the two utilized assays
had the capacity to test for 44 HPV types. In addition, the seven
ﬁbrofolliculoma skin samples were also analyzed with another
broad range HPV PCR with the primers FAP59/64 detecting up to
240 skin HPV-types (Forslund et al., 1999, 2007; Chouhy et al.,
2013). As a positive control a mixture of two DNA-extractions of
clinical samples, diluted x 1000, with cutaneous HPV57 and HPV28
was used. As a negative control 50 ng of human DNA (Sigma-
Aldrich D0711) in TE-buffer (10 mM Tris–HCl, 0.1 mM EDTA, pH
8.0) was used.
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